Skip to content

BioSig Technologies, Inc. STEX Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
Bit Digital logo
Bit DigitalBTBT
TEC
Bio-TechneTECH
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s software and technology licenses, net?
BioSig Technologies, Inc. (STEX) reported software and technology licenses, net of $15.23M in Q1 2026.
How has BioSig Technologies, Inc.'s software and technology licenses, net changed year-over-year?
BioSig Technologies, Inc.'s software and technology licenses, net increased by 34502.3% year-over-year, from $44K to $15.23M.
What is the long-term trend for BioSig Technologies, Inc.'s software and technology licenses, net?
Over 4 years (2020 to 2024), BioSig Technologies, Inc.'s software and technology licenses, net has grown at a -44.2% compound annual growth rate (CAGR), from $453.49K to $44K.